Literature DB >> 2915655

Adjuvant therapy of node-negative breast cancer.

W L McGuire.   

Abstract

Entities:  

Mesh:

Year:  1989        PMID: 2915655     DOI: 10.1056/NEJM198902233200811

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  30 in total

1.  Clinical and Histological Prognostic Factors in Axillary Node-Negative BreastCancer: Univariate and Multivariate Analysis with Relation to 5-Year Recurrence.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

2.  Cancer chemotherapy and quality of life.

Authors:  M Byrne
Journal:  BMJ       Date:  1992-06-13

3.  Biological grading of breast cancer using antibodies to proliferating cells and other markers.

Authors:  S S Bacus; R Goldschmidt; D Chin; G Moran; D Weinberg; J W Bacus
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

4.  Prognostic factors and natural history in lymph node-negative breast cancer patients.

Authors:  R Arriagada; L E Rutqvist; L Skoog; H Johansson; A Kramar
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer.

Authors:  M Stierer; H Rosen; R Weber
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

6.  Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.

Authors:  M Noguchi; T Taniya; N Ohta; N Koyasaki; I Miyazaki; Y Mizukami
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

7.  Prognosis of common cancers.

Authors:  P H Geggie
Journal:  Can Fam Physician       Date:  1990-05       Impact factor: 3.275

8.  Loss of heterozygosity on chromosome 1q in human breast cancer.

Authors:  L C Chen; C Dollbaum; H S Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.

Authors:  H Kreipe; P Alm; H Olsson; M Hauberg; L Fischer; R Parwaresch
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

Review 10.  Response to treatment of breast cancer.

Authors:  J L Berenberg
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.